New therapeutic targets in the sights of research

Cutaneous squamous cell carcinoma and basal cell carcinoma account for 99% of all cases of non-melanocytic skin cancer (NMSC). Based on an increasing understanding of the pathomechanisms that play a role in tumor development, progression and differentiation, innovative therapeutic strategies are currently being tested in studies. These include therapeutic approaches to promote anti-tumor immunity by targeting newly identified target structures.